Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS5 | Q9UNA0 | 20/20 | 1.00 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.62 |
| ▸ | MMP13 | P45452 | 7/20 | 0.61 |
| ▸ | MMP2 | P08253 | 9/20 | 0.59 |
| ▸ | ADAM17 | P78536 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21582783 | 0.86 | ADAMTS5 (0.81) | ADAMTS5MMP2ADAM17 | |
| SCHEMBL17871379 | 0.86 | ADAMTS5 (0.81) | ADAMTS5MMP2ADAM17 | |
| SCHEMBL20708446 | 0.83 | ADAMTS5 (0.86) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 | |
| SCHEMBL20708334 | 0.82 | ADAMTS5 (0.73) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 | |
| SCHEMBL20708305 | 0.81 | ADAMTS5 (0.74) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 | |
| SCHEMBL20708587 | 0.80 | ADAMTS5 (0.76) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 | |
| SCHEMBL21582749 | 0.80 | ADAMTS5 (0.75) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 | |
| SCHEMBL20708648 | 0.79 | ADAMTS5 (0.76) | ADAMTS5MMP13MMP2ADAM17 | |
| SCHEMBL20708255 | 0.78 | ADAMTS5 (0.90) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 | |
| SCHEMBL20708324 | 0.77 | ADAMTS5 (0.76) | ADAMTS5ADAMTS4MMP13MMP2ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3575294-A1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | Les Laboratoires Servier (FR) | 2019-12-04 | — | — | EP | disclosed |
| EP-3237406-B1 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS | GALAPAGOS NV (BE) | 2019-02-06 | — | — | EP | disclosed |
| US-9926281-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2018-03-27 | — | — | US | disclosed |
| US-9926281-B2 | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis | GALAPAGOS NV (BE) | 2018-03-27 | — | — | US | disclosed |